Real World Data of First-Line Treatment With Pembrolizumab for Highly PD-L1-Expressing NSCLC

JOURNAL OF THORACIC ONCOLOGY(2021)

引用 0|浏览5
暂无评分
关键词
advanced non-small cell lung cancer (NSCLC), high PD-L1 expression, treatment with pembrolizumab
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要